(+)-Benzotetramisole

CAS : 885051-07-0

Ref. 3D-FB59919

Informations sur le produit

• Nom: (+)-Benzotetramisole
• Synonymes: (+)-BTM(2R)-2,3-Dihydro-2-phenylimidazo[2,1-b]benzothiazole, imidazo[2,1-b]benzothiazole, 2,3-dihydro-2-phenyl-, (2R)-(2R)-2,3-Dihydro-2-Phenylimidazo[2,1-B]Benzothiazole, (2R)-2-Phenyl-2,3-dihydroimidazo[2,1-b][1,3]benzothiazole

Description

Benzotetramisole is a nonsteroidal anti-inflammatory drug (NSAID) that has been shown to be effective in the immobilization of rats and mice. It is an enantiopure compound with kinetic, nucleophilic, and ring-opening properties. Benzotetramisole is synthesized from β-amino acid, which undergoes a series of reactions including methanolysis, reductive amination, and ring-opening to yield the desired product. This reaction proceeds with only one enantiomer due to the presence of a chiral center on the molecule. The stereoselectivity was achieved through steric interactions at the nucleophilic site.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 252.34 g/mol
• Formule: C₁₅H₁₂N₂S
• Degré de pureté: Min. 95%
• Couleur/Forme: Solid
• InChI: InChI=1S/C15H12N2S/c1-2-6-11(7-3-1)12-10-17-13-8-4-5-9-14(13)18-15(17)16-12/h1-9,12H,10H2/t12-/m0/s1
• Code InChI: InChIKey=YGCWPCVAVSIFLO-LBPRGKRZSA-N
• SMILES: c1ccc([C@@H]2CN3C(=N2)Sc2ccccc23)cc1